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The ability of skin to maintain its protective structural
and functional integrity depends on both resident and
circulating cells. Until now, it was thought that dendritic
antigen presenting cells of epidermis (Langerhans cells)
were replaced by circulating bone marrow derived pre-
cursors. Here we show by immunostaining studies of
timed biopsies taken from human skin after ultraviolet
exposure, that hair follicle is a critical reservoir of
Langerhans cells that repopulate epidermis depleted of
Langerhans cells by a single four minimal erythema dose
of ultraviolet B. Immunostaining with antibodies to
thymidine dimers showed that ultraviolet B only pene-
trated the superficial hair follicle opening, whereas deeper
follicle was relatively protected. Langerhans cells migrat-
Epidermal Langerhans cells are specialized members of thehuman cutaneous bone marrow derived dendritic cellpopulation (Silberberg-Sinakin et al, 1976; Katz et al, 1979;Volc-Platzer et al, 1984; Breathnach, 1991), and are criticalantigen presenting cells for initiating primary T cell
mediated immune processes (i.e., delayed type hypersensitivity and
contact hypersensitivity) (Rowden et al, 1977; Toews et al, 1980;
Romani et al, 1991; Stingl and Shevach, 1991; Teunissen et al, 1997).
They normally are present as highly dendritic cells with processes
interdigitating between epidermal keratinocytes, with a cell density of
about 2%. Langerhans cells are found in many epithelia, where contact
with the external environment occurs (Rowden et al, 1977), as well
as in follicular epithelium (Breathnach, 1963), although follicular
Langerhans cells are poorly characterized. Other human leukocyte
antigen (HLA) class II positive dendritic cells are found in the dermis
(Murphy et al, 1986; Breathnach, 1991), some of which are of the
dendritic antigen presenting cell lineage (Meunier et al, 1993) that may
represent resident perivascular Langerhans cell variants, Langerhans cell
precursors migrating into skin, or activated Langerhans cells migrating
from skin.
Upon activation, the Langerhans cell phenotype changes from a cell
that efficiently takes up and processes antigen into one that efficiently
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ing from hair follicle into epidermis 72 h after ultraviolet
exposure have a partial deficiency of molecules important
to T cell costimulation. We used four color flow cyto-
metry to show that Langerhans cells isolated from epi-
dermis 72 h after ultraviolet B can upregulate CD40 but
not B7–1 or B7–2 expression in culture, suggesting a
different phenotype of hair follicle Langerhans cells.
Therefore, the hair follicle is a specialized immune com-
partment of the skin that serves as an intermediate
reservoir of Langerhans cells between bone marrow and
epidermis, and that may play a critical role in immune
surveillance. Key words: antigen presenting cells/costimulatory
molecules/dendritic cells. J Invest Dermatol 110:422–427, 1998
presents antigen to naı¨ve T cells (Schuler and Steinman, 1985; Teunissen
et al, 1997). This maturation is accompanied by the inducible expression
of several costimulatory molecules and the enhanced expression of
HLA class II molecules. Recently, dendritic cells with features of
Langerhans cells have been generated in vitro from human neonatal
cord blood stem cell precursors (Caux et al, 1992) and from peripheral
blood precursors (Sallusto and Lanzavecchia, 1994) using specialized
culture conditions [granulocyte-macrophage colony stimulating factor,
interleukin (IL)-4, and tunor necrosis factor-α]; however, the source
(resident dermal precursors or blood derived dendritic cells) of
Langerhans cells in epidermis in vivo and their maturation steps are
not known.
A useful model for the study of Langerhans cell entry into skin and
phenotype after functional challenge is ultraviolet B (UVB) exposed
skin (Cruz and Bergstresser, 1991). After UVB exposure, epidermal
Langerhans cells are decreased in density and altered in morphology,
becoming less dendritic (Toews et al, 1980). At 72 h, CD1a1 Langerhans
cells are markedly decreased in numbers in UVB exposed epidermis
and do not begin to reappear in large numbers until days 4–6 (Toews
et al, 1980; Aberer et al, 1981); their disappearance is closely related in
time to the development of an immunosuppressive environment and
antigen specific tolerance to epicutaneous hapten (Streilein et al, 1980;
Cooper et al, 1992). By 72 h, depletion of cells bearing HLA-DR but
not OKT6 from epidermal suspensions reduces T cell proliferation in
allogeneic epidermal cell-lymphocyte reactions, showing indirectly that
at that time, Langerhans cells are not significantly contributing to
induction of T cell proliferation by UV exposed skin (Cooper et al,
1985). At the same time that Langerhans cells disappear from the
epidermis, infiltration of first the dermis and later the epidermis by IL-
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10 producing CD11b1 monocyte/macrophages (Kang et al, 1994)1
that are deficient in CD40, B7, and IL-122 and that induce T cell
proliferation well is seen.
We report here that the hair follicle is a reservoir for epidermal
Langerhans cells after UVB injury to human skin. (This follicular
reservoir paradigm is also seen in cutaneous thermal injury and in the
autoimmune disease vitiligo, in which follicular keratinocytes and
melanocytes replenish epidermal cell populations.) After UVB,
Langerhans cells in follicular epithelium divide and appear to migrate
from follicular infundibulum into surrounding epidermis. In addition,
the early repopulating epidermal Langerhans cells present 72 h after
UVB show an altered phenotype compared with Langerhans cells from
unirradiated epidermis. These Langerhans cells have a selectively
reduced capacity to express the costimulatory markers B7–1 and B7–
2, but not CD40, in culture compared with Langerhans cells from
unexposed control skin, suggesting an intermediate maturation step in
the transition from hair follicle to epidermis with possible implications
for T cell activation. Because of the demonstrated linkage of susceptibil-
ity in animals (Kripke and Fisher, 1976) and humans (Yoshikawa
et al, 1990) to UVB induced skin tumors with development of an
immunosuppressive state in UVB exposed skin, our data suggest the
importance of a mechanism for a more rapid recovery of the protective
cutaneous immune system after UVB than may be possible from blood
precursors alone.
MATERIALS AND METHODS
Subjects Healthy adult volunteers (n 5 8) participated in the study after
Institutional Review Board approval of the protocol and informed consent. As
described previously (Cooper et al, 1992), four minimal erythema dose (MED)
was delivered to buttock skin from Westinghouse FS20 bulbs at different time
points. At the final time point, punch biopsies or keratomes were obtained
from all UVB exposed and nonirradiated control sites.
Immunohistochemical studies
Antibodies Immunostaining was performed at least three times on each specimen
with the following primary mouse monoclonal antibodies: CD1a (B17.20.9,
IgG2a; Immunotech, Westbrook, ME), CD11b (anti-Mac-1/Bear 1, IgG1;
Immunotech), Ki-67 (Ki-S5, IgG1; Boehringer, Indianapolis, IN), and anti-
bodies to cyclobutane pyrimidine dimers (TDM-2, IgG2a; gift of Dr. Osamu
Nikaido, Kanazawa University, Japan). Secondary antibodies used for immuno-
peroxidase studies were biotin conjugated goat anti-mouse IgG1 or IgG2a
(Caltag, San Francisco, CA) followed by peroxidase labeled streptavidin (Kirke-
gaard & Perry, Gaithersburg, MD). Double immunofluorescence staining for
Ki-67 and CD1a was performed using fluorescein isothiocyanate conjugated
goat anti-mouse IgG1 for Ki-67 (Boehringer), and biotin conjugated goat anti-
mouse IgG2a for CD1a followed by Rhodamine Red-x conjugated avidin
(Neutr-Avidin, Molecular Probes, Leiden, The Netherlands).
Immunohistochemical procedures Six micrometer frozen sections were blocked
with 10% goat serum, treated with primary antibody or its isotype control
immunoglobulin, treated with biotin conjugated secondary antibody, peroxidase
conjugated streptavidin (Kirkegaard & Perry), then detected with Diaminobenzi-
dine Reagent Set (DAB) (Kirkegaard & Perry) and counterstained with
hematoxylin. Before staining frozen tissue sections with antibodies to cyclo-
butane thymidine dimers (TDM-2), nuclear DNA was denatured with 70 mM
NaOH in 70% ethanol for 2 min, followed by neutralization for 1 min in
100 mM Tris-HCL, pH 7.5 in 70% ethanol, three washes of 70% ethanol, and
two washes of phosphate buffered saline (Chadwick et al, 1995).
Microscopy and photography Images from immunostaining experiments were
obtained using a Zeiss (Thornwood, NY) Axiophot microscope and Kodak
(Rochester, NJ) Ektachrome 160T film (bright field studies) or P1600 film
(immunofluorescence studies). These were scanned (SprintScan, Polaroid,
Cambridge, MA) and formatted as tiff images in Adobe Photoshop and Illustrator.
Analysis: quantitation of CD1a1 cells CD1a1 cells in the upper area of the
1Gilliam AC, Moser A, Tootell E, Kang K, Cooper KD: Distinct physical
and temporal compartments of antigen-presenting cells and IL-10 and TNFα
expression in human UV-exposed skin by in situ hybridization and
immunostaining. J Invest Dermatol 108:638, 1997 (abstr.)
2Kremer IB, Cooper KD, Teunissen MBM, Stevens SR: Diminished CD40
expression on macrophages infiltrating UV-exposed skin is responsible for IL-
2Rα– T cell activation. J Invest Dermatol 108:538, 1997 (abstr.)
follicle and in the epidermis adjacent to the follicle were counted in unirradiated
control skin and in skin 72 h after UVB using an ocular micrometer grid with
3200 magnification. The compartments are delineated as A–E with the areas
of A, B1 1 B2, C1 1 C2, D1 1 D2, and E1 1 E2, each corresponding to
0.0625 mm2 (Fig 4). After counting the number of CD1a1 cells in three
sections per individual specimen (n 5 3), CD1a1 cells in UVB irradiated skin
were expressed as a percentage (6 SEM) of the mean count in the equivalent
compartment in unirradiated control skin.
Flow cytometry
Antibodies For flow cytometry, the following mouse monoclonal antibodies
were used: biotin conjugated anti-HLA-DR (IgG2a; Becton Dickinson,
Mountain View, CA), fluorescein isothiocyanate conjugated anti-CD1a (IgG1;
Ortho, Raritan, NJ), and anti-CD40 (IgG1; Pharmingen, San Diego, CA),
phycoerythrin conjugated anti-CD1a (OKT6; IgG1; Ortho), anti-B7–1 (CD80;
IgG1; Becton Dickinson), anti-B7–2 (CD86; IgG1; Ancell, Bayport, MN), or
isotype matched control antibodies from the same companies. Cascade-Blue-
streptavidin was purchased from Molecular Probes (Eugene, OR).
Flow cytometry protocol Keratome biopsies were obtained 72 h after four MED
of UVB as previously described (Meunier et al, 1993). Epidermis was separated
from dermis by incubation in dispase, digested in trypsin, and dissociated in
0.1% DNase (Sigma, St Louis, MO) in Hanks balanced salt solution containing
10% fetal bovine serum (Hyclone, Logan, UT). The suspension was filtered
through 100 µm nylon mesh and cultured for 24 h in vitro in RPMI with 10%
heat inactivated human AB serum (North American Biology, Miami, FL) to
allow costimulatory molecule expression. Cells were incubated with human
IgG (Sigma) to prevent nonspecific Fc receptor binding. Dead cells were
identified by addition of ethidium monoazide (Molecular Probes) for 10 min
under visible light for cross-linkage to DNA. Flow cytometry was performed
using an Epics Elite (Coulter Cytometry).
RESULTS
Human hair follicle is a reservoir for Langerhans cells in skin
depleted of epidermal Langerhans cells by UVB When human
skin is exposed to four MED of UVB, interfollicular epidermal
Langerhans cells (Fig 1a–d, arrows) become less dendritic and are
decreased in number after 24 h, with almost complete disappearance
of CD1a1 cells at 72 h. Note the occasional CD1a1 dermal Langerhans
cell-like cells in control unirradiated skin (Fig 1a) but not in irradiated
skin. Lower power views of skin specimens from a single subject show
numerous CD1a1 Langerhans cells in both follicular epithelium and
epidermis in control tissue (Fig 2a, arrows). At later time points after
UVB (48, 72, 96 h, Fig 2b–d, respectively), CD1a1 cells are absent
in interfollicular epidermis and dermis, but appear in and adjacent to
follicles. At 96 h (Fig 2d), there are clearly increased numbers of
CD1a1 cells in the follicular orifice and in the adjacent epidermis. At
the same time, the epidermis and dermis at some distance from follicles
showing prominent UVB injury (necrosis of epidermal keratinocytes)
still lack CD1a1 cells. The CD1a1 cells in perifollicular epidermis
adjacent to follicles at 48, 72, and 96 h may represent either Langerhans
cells that are migrating from follicle to epidermis, or Langerhans cells
left in the epidermis after UVB injury; the immunostaining results of
this time course showing CD1a1 cells at progressive distances from
the follicular orifice, suggest that Langerhans cells are migrating from
follicle to epidermis. These changes can be appreciated in the low
power view of a biopsy taken 72 h after UVB exposure from another
subject (n 5 3, Fig 3a). The immunostaining results presented here
are representative of those in all biopsies from all patients.
Immunostaining of sections containing follicles from the same
specimen with CD11b/CD18 (Mac-1) (Fig 3b) highlights the unique
character of follicular epithelium and of epidermis adjacent to follicles
after UVB; numerous infiltrating Mac-11 macrophages are seen in
epidermis and dermis at some distance from but not adjacent to or
within follicles, presenting the reverse image of CD1a staining (Fig 3a).
Therefore, the hair follicle appears to be a relatively protected environ-
ment for and serves as a source of Langerhans cells that begin to
replenish the epidermis 48 h after four MED UVB. Meanwhile, the
epidermis at some distance from the follicle is injured, without CD1a1
cells, and is a site for migration of and infiltration by Mac-11
macrophages. Further support of follicular Langerhans cells as a reservoir
for epidermal Langerhans cells is the observation that the other possible
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Figure 1. UVB-induced changes in
epidermal Langerhans cells. Interfollicular
CD1a1 epidermal Langerhans cells in human
skin irradiated with four MED UVB change
in morphology and numbers, becoming less
dendritic at 6 h (b), depleted in number at
24 h (c), and completely absent by 72 h (d),
compared with control unirradiated skin (a).
Immunoperoxidase staining with CD1a
(brown staining cells, arrows) of tissue collected
at time points after UVB. Note occasional
CD1a1 dermal cells in control skin (a) but
not in irradiated skin. Scale bar, 43 µm.
Figure 2. UVB-induced changes in hair
follicle Langerhans cells. CD1a1 Langerhans
cells (brown staining cells, arrows) at time points
after four MED UVB [(a) control unirradiated
skin, (b) 48 h, (c) 72 h, (d) 96 h] are present in
progressively increased numbers in the follicular
opening, whereas interfollicular epidermis
distant from the hair follicle becomes devoid of
CD1a1 cells. Sclae bar, 138 µm.
Figure 3. Langerhans cells and macro-
phages occupy different compartments in
UV-exposed skin. Lower power views of a
biopsy specimen of skin 72 h after four MED
UVB stained with CD1a (a) or CD11b (b) show
that CD1a1 Langerhans cells and CD11b1
macrophages are present in distinctly different
compartments in the skin after UVB. Scale bar,
344 µm.
source of Langerhans cells migrating to the epidermis (papillary dermis)
contains few if any CD1a1 cells at 48, 72, or 96 h after UVB
(Fig 2b–d, 3a).
To quantitatively document that follicular epithelium contains
increased numbers of Langerhans cells 72 h after UVB, we counted
CD1a1 cells in epidermal compartments (n 5 3, inset, Fig 4).
Epithelium at the follicular orifice (inset: A, B1 1 B2) contains
significantly more CD1a1 cells than the immediately adjacent epidermis
(C1 1 C2, D1 1 D2, and E1 1 E2). As Fig 4 shows, the numbers
of Langerhans cells decrease with increasing distance from the hair
follicle, with 100% representing control unirradiated skin.
Deep follicular epithelium is protected from UVB It has been
shown that UVB only reaches the epidermis and superficial dermis
(Bruls et al, 1984). To evaluate the depth of direct UVB exposure in
our skin samples and to show that follicular epithelium is relatively
photoprotected, we performed immunostaining of biopsy tissue taken
from buttock skin 10 min after UVB with antibodies to cyclobutane
pyrimidine dimers (Qin et al, 1994; Vink et al, 1996). We confirmed
that fewer thymidine dimers are found at increasing depth in the
epidermis. Figure 5(a) shows no staining in control unirradiated skin,
whereas Fig 5(b) shows numerous positive cells in the epidermis and
superficial papillary dermis but not in the deeper follicle, with a sharp
line of demarcation in the superficial portion of the hair follicle,
showing that infundibulum and deep follicular epithelium are indeed
protected from UVB radiation.
Proliferating Langerhans cells are found in the hair
follicle Immunostaining with Ki-67, which stains nuclei of cells in
cycle (Gerdes et al, 1984), identifies numerous proliferating cells in
follicular epithelium 72 h after UVB. Double-staining immunofluores-
cence studies using anti-Ki-67 (fluorescein isothiocyanate) and anti-
CD1a (rhodamine) (Fig 6) show that admixed with the green nuclei
of Ki-671 proliferating keratinocytes are occasional cells with yellow
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Figure 4. The numbers of CD1a1 cells 72 h after four MED UVB are
high in the hair follicle and in the adjacent epidermis and form a
gradient inversely related to distance from the follicle. The numbers of
CD1a1 cells per square grid (0.0625 mm2) in the upper area of the follicle and
in the epidermis near the follicle were counted in unirradiated control skin and
in skin 72 h after UVB using an ocular micrometer grid under the microscope.
The image in the right corner shows the square compartments (A–E) defined
for counting. The percentage of CD1a1 cells 6 SEM in each compartment
(mean of three experiments) at 72 h versus control unirradiated skin (100%)
is presented.
Figure 5. Deep follicular epithelium is protected from UVB. The depth
of penetration (————) of UV in skin collected 10 min after a single dose
of four MED UVB is shown by the presence of thymidine dimers (brown
staining keratinocyte nuclei) in the epidermis and the upper follicular epithelium.
Protected follicular epithelium deep to the infundibulum shows no thymidine
dimers. Scale bar, 138 µm; inset, 72 µm.
double-staining nuclei (white arrow) and red dendritic cell bodies that
are positive for both CD1a and Ki-67, representing proliferating
Langerhans cells. Therefore, although the majority of proliferating cells
in the follicular epithelium of UVB irradiated skin are keratinocytes,
there are also proliferating Langerhans cells. Hair follicles in control
Figure 6. Proliferating Langerhans cells are found in the hair follicle.
Occasional proliferating Langerhans cells are seen in the follicular epithelium
when double stained for CD1a (red staining dendritic cell bodies) and for Ki-
67 (yellow nuclei, white arrows) at 72 h after UVB. The remainder of Ki-671
cell nuclei staining green represent keratinocytes in the cell cycle. Scale bar, 26 µm.
skin also showed a few CD1a1Ki-671 cells (not shown); the numbers
in both UV and control conditions are small.
Newly migrating follicular Langerhans cells are deficient in
upregulation of B7 but not of CD40 costimulatory
molecules We next asked if the Langerhans cells present in UVB
exposed epidermis 72 h after UVB, which are predominantly associated
with the hair follicle (Figs 2b–d, 3a, 4), are normal Langerhans cells.
The ability of Langerhans cells to stimulate T cells depends on the
presence of surface costimulatory molecules such as B7 and CD40
(Foy et al, 1996; Lenschow et al, 1996). Therefore, we investigated
the expression of these costimulatory molecules using flow cytometry
of Langerhans cells purified from control or UVB irradiated epidermis
72 h after four MED UVB, when Langerhans cells present in cell
suspensions are likely to be those that have migrated from the hair
follicle. [We verified that in routine histology of intact keratome and
in dispase-split epidermal and dermal components of the keratome,
the upper region of the hair follicle stays with the epidermis (not
shown).] Epidermal cell suspensions were cultured in vitro for 24 h to
mimic the maturation process observed when Langerhans cells migrate
from the skin to the lymph nodes (Schuler and Steinman, 1985). After
1 d of culture, as expected, Langerhans cells from control skin strongly
expressed B7–1, B7–2, and CD40 (Fig 7a, left panels, b). In contrast,
Langerhans cells from UVB irradiated skin essentially failed to upregulate
B7–1 or B7–2 during culture, but were clearly positive for newly
expressed CD40 removed by trypsinization (Fig 7a, right panels, b),
evidence for a partial deficit in costimulatory molecule expression.
Although migration in this ex vivo model cannot be directly studied,
together these data suggest that follicular Langerhans cells are sources
for replenishment of epidermal Langerhans cells after a single dose of
UVB, and that additional not yet characterized maturation steps occur
after their migration into epidermis.
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DISCUSSION
This study demonstrates the critical and unique role of hair follicles in
the immune system of the skin. We show that Langerhans cells
proliferate in and migrate from the hair follicle into UVB exposed
epidermis, beginning to repopulate the epidermis as early as 48 h after
a single dose of four MED UVB. The ability of Langerhans cells to
divide and migrate is known (Miyauchi and Hashimoto, 1987); the
factors that induce Langerhans cell division, maintain Langerhans cell/
keratinocyte ratios in epidermis, and initiate migration are not well
characterized.
Based on bone marrow transplantation studies of lethally irradiated
mice and humans, in which repopulation of epidermis by Langerhans
cells was shown to be entirely by cells with donor phenotype (Katz
et al, 1979; Volc-Platzer et al, 1984), the route of entry into skin
appeared to be via blood borne precursors originating in bone marrow.
Whether these precursors take up residence in the perivascular dermis,
enter directly into the epidermis, or enter the epidermis via the hair
follicle is unknown. The present data using a physiologic skin challenge
of a single four MED of UVB, which results in almost complete
depletion of interfollicular epidermal CD1a1 cells, indicate that one
pathway for repopulation of epidermal Langerhans cells is a local one
via the hair follicle.
This study suggests that newly emigrated follicular Langerhans cells
have a different phenotype than interfollicular epidermal Langerhans
cells, in that they are able to induce CD40 but not B7 expression in
culture; the properties acquired in culture are thought to model
the functional changes that occur during stimulated Langerhans cell
migration from the epidermis to regional lymph nodes. The afferent
pathway of Langerhans cell trafficking from blood and tissue into
epidermis is less well understood; our data identifying follicular
Langerhans cells as a resource for epidermal Langerhans cells will be
useful for dissecting out that differentiation pathway. Because T cell
activation in the absence of B7 costimulation can result in antigen
specific unresponsiveness (Gimmi et al, 1993), the presence of B7
deficient Langerhans cells in UV exposed skin is likely to have
consequences for immune activation and tolerance induction.
Changes in the cytokine environment in UVB irradiated skin, such
as the presence of IL-10 producing UV macrophages, will also influence
the phenotype of Langerhans cells repopulating the epidermis from
the hair follicle, because IL-10 can directly downregulate B7 expression
(Ding et al, 1993; Ozawa et al, 1996). Therefore, Langerhans cells in
the hair follicle may be exposed to different microenvironments of
cytokines and growth factors as they migrate to the epidermis following
UVB. Further studies of the follicular and epidermal microenvironments
in which Langerhans cells reside will provide important information
about possible mechanisms of Langerhans cell maturation and function,
and roles in immune surveillance.
Note added in proof: Follicular infundibular Langerhans cells may also
replenish epidermis in chronically UV-exposed human skin (Murphy
et al, 1998).
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